FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valera, A.
Right arrow Articles by Bosch, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valera, A.
Right arrow Articles by Bosch, F.

The FASEB Journal, Vol 7, 791-800, Copyright © 1993 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Glucose metabolism in transgenic mice containing a chimeric P- enolpyruvate carboxykinase/bovine growth hormone gene

A Valera, JE Rodriguez-Gil, JS Yun, MM McGrane, RW Hanson and F Bosch
Department of Biochemistry, School of Veterinary Medicine, Autonomous University of Barcelona, Spain.

Transgenic mice, containing the chimeric gene obtained by linking the promoter-regulatory region of P-enolpyruvate carboxykinase (PEPCK) gene to the bovine growth hormone structural gene (bGH), were used to investigate the long-term effects of bGH on glucose metabolism. Expression of the PEPCK/bGH gene was markedly enhanced by feeding a diet high in protein and inhibited by a high carbohydrate diet. All transgenic mice had normal levels of blood glucose but were hyperinsulinemic, indicating that they were insulin resistant. The glycogen synthase activity ratios in the muscle and liver of transgenic mice were lower than noted for control animals, and remained unchanged in liver after feeding a standard high carbohydrate or a high protein diet. Similar effects were detected in the activity of glycogen phosphorylase, except that a high carbohydrate diet activated this enzyme in the liver. The activation of glycogen phosphorylase in both muscle and liver correlated with the expression of their genes. These animals had a significant content of glycogen and glucose 6-phosphate, which was related to the levels of glucokinase mRNA in the liver. The concentration of fructose 2,6-bisphosphate in the liver of all fed transgenic mice was lower than noted in livers from fed animals. In addition, a decrease in the hepatic expression of the endogenous genes for PEPCK, tyrosine aminotransferase (TAT), and the glucose transporter GLUT-2 was observed and directly correlated with the expression of bGH. Thus, bGH can control glucose metabolism in vivo, at least in part, by modifying the expression of several genes coding for proteins of importance in carbohydrate metabolism. Taken together, these results indicate a state of insulin resistance caused by chronic exposure of the animals to an elevated concentration of bGH.


This article has been cited by other articles:


Home page
EndocrinologyHome page
Z. Wang, M. M. Masternak, K. A. Al-Regaiey, and A. Bartke
Adipocytokines and the Regulation of Lipid Metabolism in Growth Hormone Transgenic and Calorie-Restricted Mice
Endocrinology, June 1, 2007; 148(6): 2845 - 2853.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Cho, M. Ariga, Y. Uchijima, K. Kimura, J.-Y. Rho, Y. Furuhata, F. Hakuno, K. Yamanouchi, M. Nishihara, and S.-I. Takahashi
The Novel Roles of Liver for Compensation of Insulin Resistance in Human Growth Hormone Transgenic Rats
Endocrinology, November 1, 2006; 147(11): 5374 - 5384.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Eleswarapu and H Jiang
Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver
J. Endocrinol., January 1, 2005; 184(1): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
J. C. Velez and S. S. Donkin
Bovine Somatotropin Increases Hepatic Phosphoenolpyruvate Carboxykinase mRNA in Lactating Dairy Cows
J Dairy Sci, May 1, 2004; 87(5): 1325 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sun, S. Liu, S. Ferguson, L. Wang, P. Klepcyk, J. S. Yun, and J. E. Friedman
Phosphoenolpyruvate Carboxykinase Overexpression Selectively Attenuates Insulin Signaling and Hepatic Insulin Sensitivity in Transgenic Mice
J. Biol. Chem., June 21, 2002; 277(26): 23301 - 23307.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
F. P. Dominici and D. Turyn
Growth Hormone-Induced Alterations in the Insulin-Signaling System
Experimental Biology and Medicine, March 1, 2002; 227(3): 149 - 157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Frick, M. Bohlooly-Y, D. Linden, B. Olsson, J. Tornell, S. Eden, and J. Oscarsson
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1230 - E1239.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. P. Dominici, D. Cifone, A. Bartke, and D. Turyn
Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E447 - E454.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Costa, G. Solanes, J. Visa, and F. Bosch
Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus
FASEB J, November 1, 1998; 12(14): 1455 - 1460.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by The Federation of American Societies for Experimental Biology.